Stock Price
21.86
Daily Change
-0.90 -3.95%
Monthly
-8.65%
Yearly
10.12%
Q2 Forecast
22.67

EPS Reference Time Actual Consensus Previous
2026-05-12 FY2026Q1 0.18 0.14
2026-03-03 FY2025Q4 0.17 0.2 0.20
2025-11-04 FY2025Q3 0.21 0.18 0.17
2025-08-05 FY2025Q2 0.23 0.17 0.20
2025-05-06 FY2025Q1 0.14 0.18 0.12



Peers Price Chg Day Year Date
Alliar Medicos A Frente 3.99 0.04 1.01% -46.80% Apr/02
Marisa Lojas 0.87 0 0% -40.00% Apr/02
Arezzo Industria e Comercio 25.16 -0.29 -1.14% -1.60% Apr/02
Americanas 5.40 -0.11 -2.00% -15.49% Apr/02
C&A Modas 12.04 -0.17 -1.39% -0.08% Apr/02
Clicks 29,451.00 -238.00 -0.80% -11.09% Apr/02
Grup SBF 12.44 -0.01 -0.08% 6.84% Apr/02
Cogna Educacao 3.18 -0.03 -0.93% 45.87% Apr/02
Fleury 15.88 -0.15 -0.94% 32.89% Apr/02
Fomento Economico Mexicano 114.74 1.64 1.45% 13.09% Apr/02

Indexes Price Day Year Date
IBOVESPA 188052 99.11 0.05% 43.40% Apr/02

Raia Drogasil traded at 21.86 this Thursday April 2nd, decreasing 0.90 or 3.95 percent since the previous trading session. Looking back, over the last four weeks, Raia Drogasil lost 8.65 percent. Over the last 12 months, its price rose by 10.12 percent. Looking ahead, we forecast Raia Drogasil to be priced at 22.67 by the end of this quarter and at 20.89 in one year, according to Trading Economics global macro models projections and analysts expectations.

Raia Drogasil SA is a Brazil-based company engaged in retail sales of medications, specialty medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. The Company’s sales are carried out by over 860 stores, located in the states of Sao Paulo, Minas Gerais, Rio de Janeiro, Parana, Goias, Espirito Santo, Santa Catarina, Rio Grande do Sul, Bahia, Mato Grosso and Mato Grosso do Sul and in the Distrito Federal. The Company operates through a range of subsidiaries, such as Raia SA and 4-Bio Medicamentos SA.